The DOI matches its Crossref record; the references it cites are not checked yet.
Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell Sequencing
Open accessAbstract
Background: Advances in single-cell sequencing provide unprecedented opportunities for clinical examination of circulating tumor cells, cancer stem cells, and other rare cells responsible for disease progression and drug resistance. On the genomic level, single-cell whole exome sequencing (scWES) started to gain popularity with its unique potentials in characterizing mutational landscapes at a single-cell level. Currently, there is little known about the performance of different exome capture kits in scWES. Nextera rapid capture (NXT; Illumina, Inc.) has been the only exome capture kit recommended for scWES by Fluidigm C1, a widely accessed system in single-cell preparation. Results: In this study, we compared the performance of NXT following Fluidigm’s protocol with Agilent SureSelectXT Target Enrichment System (AGL), another exome capture kit widely used for bulk sequencing. We created DNA libraries of 192 single cells isolated from spheres grown from a melanoma specimen using Fluidigm C1. Twelve high-yield cells were selected to perform dual-exome capture and sequencing using AGL and NXT in parallel. After mapping and coverage analysis, AGL outperformed NXT in coverage uniformity, mapping rates of reads, exome capture rates, and low PCR duplicate rates. For germline variant calling, AGL achieved better performance in overlap with known variants in dbSNP and transition-transversion ratios. Using calls from high coverage bulk sequencing from blood DNA as the golden standard, AGL-based scWES demonstrated high positive predictive values, and medium to high sensitivity. Lastly, we evaluated somatic mutation calling by comparing single-cell data with the matched blood sequence as control. On average, 300 mutations were identified in each cell. In 10 of 12 cells, higher numbers of mutations were identified using AGL than NXT, probably caused by coverage depth. When mutations are adequately covered in both AGL and NXT data, the two methods showed very high concordance (93–100% per cell). Conclusions: Our results suggest that AGL can also be used for scWES when there is sufficient DNA, and it yields better data quality than the current Fluidigm’s protocol using NXT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
References 27 · Cited by 8
Metadata
- Authors
- Huss, W. J., Hu, Q., Glenn, S. T., Gangavarapu, K. J., Wang, J., Luce, J. D., Quinn, P. K., Brese, E. A., Zhan, F., Conroy, J. M., Paragh, G., Foster, B. A., Morrison, C. D., Liu, S., & Wei, L.
- Affiliations
- Roswell Park Comprehensive Cancer Center (US)
- University of Science and Technology of China (CN)
- ORCID
- Venue
- Human Heredity
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 83
- Issue
- 3
- Pages
- 153-162
- ISSN
- 0001-5652 (ISSN-L)
- 1423-0062
- PMC
- PMC7868962
- OpenAlex
- W2913382714
- Cited by
- 8
- References
- 27
- Citations by year
- 2026: 1 · 2023: 1 · 2021: 3 · 2020: 2 · 2019: 1
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Human Heredity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50CA159981, P30CA016056)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- melanoma, somatic mutation calling, germline variant calling, circulating tumor cells
- MeSH terms
- Germ Cells, Humans, Mutation, Genetic Variation, Polymorphism, Single Nucleotide, Single-Cell Analysis, High-Throughput Nucleotide Sequencing, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell Sequencing. https://app.cochat.ai/papers/10.1159/000490506
- The paper
- Huss, W. J., Hu, Q., Glenn, S. T., Gangavarapu, K. J., Wang, J., Luce, J. D., Quinn, P. K., Brese, E. A., Zhan, F., Conroy, J. M., Paragh, G., Foster, B. A., Morrison, C. D., Liu, S., & Wei, L. (2018). Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell Sequencing. Human Heredity. https://doi.org/10.1159/000490506
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.